Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999

J Card Fail. 2005 May;11(4):270-8. doi: 10.1016/j.cardfail.2004.11.003.

Abstract

Abstract Background Community and hospital studies have suggested that survival of patients with heart failure (HF) has increased; however, the causes of the improvement and the hospital readmission rates remain undetermined. Methods and Results We compared survival and hospital admission rates in 2 cohorts enrolled in a national registry of outpatients with HF secondary to left ventricular (LV) systolic dysfunction referred to cardiology centers in 1995 (n = 712) and 1999 (n = 603). One year after enrollment, 163 of 1315 patients (12%) were dead. Survival rates were 85% in the 1995 versus 91% in the 1999 cohort. Older age, New York Heart Association (NYHA) class III-IV, anemia, hyponatremia, hypotension, and a lower LV ejection fraction (LVEF) were associated to an increased risk of all-cause mortality by multivariate analysis. Furthermore a significant independent cohort effect was observed: the adjusted risk of death was 1.30 (95% CI 1.16-1.45) for the 1995 versus 1999 cohort (survival difference adjusted P = .0067). The proportion of patients admitted to hospital declined significantly in 1999 versus 1995, for all causes (20% versus 27%, P = .006), for cardiac causes (16% versus 22%, P = .002), and for worsening congestive heart failure (8% versus 15%, P = .0005). Survival free from HF admission was 69% in 1995 versus 84% in 1999 (adjusted P = .0001); NYHA class III-IV, hypotension, diuretics and a lower LVEF were associated to an increased risk of this combined end point by multivariate analysis, as well as the enrollment year (relative risk 1.38, 95% CI 1.22-1.56, P = .0039). Conclusion In a national cardiologic registry of outpatients with systolic HF, survival improved and hospital admissions decreased over a 4-year period. These results underscore the importance of networking and the careful implementation of practice guidelines to elevate standards of care.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Aged
  • Anemia / epidemiology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cohort Effect
  • Cohort Studies
  • Disease-Free Survival
  • Diuretics / therapeutic use
  • Female
  • Follow-Up Studies
  • Heart Failure / epidemiology
  • Heart Failure / mortality*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Hyponatremia / epidemiology
  • Hypotension / epidemiology
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Patient Admission / statistics & numerical data
  • Prospective Studies
  • Sex Factors
  • Stroke Volume / physiology
  • Survival Rate
  • Ventricular Dysfunction, Left / epidemiology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics